New MDMA and Psilocybin prescription rules
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 7:28 — 10.3MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
The Therapeutic Goods Administration shocked the health sector earlier this year when it announced that from 1 July, authorised psychiatrists would be able to prescribe MDMA to assist treatment of post-traumatic stress disorder, and psilocybin, the active ingredient in magic mushrooms, for treatment-resistant depression.
Guest: Professor Susan Rossell – Cognitive Neuropsychologist and Professorial Research Fellow, Swinburne Centre for Mental Health
Presenter: Warren Andrew
Podcast: Play in new window | Download (Duration: 7:28 — 10.3MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Associate Professor Liam Burke: What Netflix Buying Warner Bros Could Mean for Cinema
Netflix’s move to buy Warner Bros has raised questions about the future of cinema. Associate Professor Liam Burke explains the ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:49 — 13.5MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Associate Professor Lauren Rosewarne: Why Christmas Songs Get Stuck in Our Heads
Christmas music triggers instant memories, emotions and associations, often within seconds of hearing it. Associate Professor Lauren Rosewarne explains why ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:47 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Lee Knight: Preventing Domestic Violence Before It Happens
A world-first Australian trial is exploring whether treating impulsivity could help prevent domestic and family violence before harm occurs. Lee ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 12:24 — 17.0MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS